학술논문
The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: A marker of response to antitumoural treatment in metastatic renal cell carcinoma
Document Type
Article
Author
Source
In: British Journal of Cancer . (British Journal of Cancer, 1 May 2018, 118(9):1179-1188)
Subject
Language
English
ISSN
15321827
00070920
00070920